AbbVie
ABBV
#31
Rank
$298.11 B
Marketcap
$166.09
Share price
-0.96%
Change (1 day)
20.59%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of March 2024 : $8.04 B

According to AbbVie's latest financial reports the company has $8.04 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$10.39 B-39.86%
2022-12-31$17.28 B11.99%
2021-12-31$15.43 B17.86%
2020-12-31$13.09 B-260.27%
2019-12-31$-8.18 B-3.24%
2018-12-31$-8.45 B-265.71%
2017-12-31$5.09 B9.94%
2016-12-31$4.63 B17.52%
2015-12-31$3.94 B126.46%
2014-12-31$1.74 B-61.22%
2013-12-31$4.49 B33.57%
2012-12-31$3.36 B-71.82%
2011-12-31$11.93 B-24.01%
2010-12-31$15.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$92.55 B 1,050.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.89 B 60.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.02 B-37.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.21 B 89.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.45 B 116.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.54 B 105.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$37.50 B 366.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
$16.71 B 107.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.38 B-70.35%๐Ÿ‡บ๐Ÿ‡ธ USA